 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Diffusion Pharmaceuticals Inc. (DFFN)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2016-12-27 Purchase | 2016-12-28 4:15 pm | Diffusion Pharmaceuticals Inc. | DFFN | Giles Mark T Director | 290,580 | $0 | $0 | 802,689 (Indirect) | View |
| 2016-12-14 Purchase | 2016-12-16 5:00 pm | Diffusion Pharmaceuticals Inc. | DFFN | Giles Mark T Director | 512,109 | $0 | $0 | 512,109 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-01-02 Option Award | 2020-01-30 4:55 pm | N/A 2030-01-31 | Diffusion Pharmaceuticals Inc. | DFFN | Gainer John Chief Scientific Officer | 239,400 | $0.46 | 239,400 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-30 4:54 pm | N/A 2030-01-31 | Diffusion Pharmaceuticals Inc. | DFFN | Kalergis David G CEO Chairman | 262,900 | $0.46 | 262,900 (Direct) | View |
| 2020-01-02 Option Award | 2020-01-30 4:54 pm | N/A 2030-01-31 | Diffusion Pharmaceuticals Inc. | DFFN | Hornung William Karl CFO | 52,600 | $0.46 | 52,600 (Direct) | View |
| 2020-01-07 Option Award | 2020-01-13 5:11 pm | N/A 2021-06-30 | Diffusion Pharmaceuticals Inc. | DFFN | Cobuzzi Robert Joseph Jr. Director | 118,600 | $0.42 | 98,100 (Direct) | View |
| 2020-01-07 Option Award | 2020-01-13 5:11 pm | N/A 2022-12-31 | Diffusion Pharmaceuticals Inc. | DFFN | Cobuzzi Robert Joseph Jr. Director | 98,100 | $0.51 | 98,100 (Direct) | View |
| 2020-01-07 Option Award | 2020-01-09 5:03 pm | N/A 2022-12-31 | Diffusion Pharmaceuticals Inc. | DFFN | Byrne Thomas E General Counsel | 25,000 | $0.42 | 25,000 (Direct) | View |
| 2019-06-13 Option Award | 2019-08-06 08:53 am | N/A 2029-06-13 | Diffusion Pharmaceuticals Inc. | DFFN | Adams Robert W Director | 19,200 | $3.15 | 19,200 (Direct) | View |
| 2019-06-13 Option Award | 2019-08-06 08:53 am | N/A 2029-06-13 | Diffusion Pharmaceuticals Inc. | DFFN | Giles Mark T Director | 19,200 | $3.15 | 19,200 (Direct) | View |
| 2019-06-13 Option Award | 2019-08-06 08:53 am | N/A 2029-06-13 | Diffusion Pharmaceuticals Inc. | DFFN | LEVIN ALAN G Director | 19,200 | $3.15 | 19,200 (Direct) | View |
| 2019-06-13 Option Award | 2019-07-19 3:01 pm | N/A 2029-06-13 | Diffusion Pharmaceuticals Inc. | DFFN | Adams Robert W Director | 13,100 | $3.15 | 13,100 (Direct) | View |
| 2019-06-13 Option Award | 2019-07-19 3:00 pm | N/A 2029-06-13 | Diffusion Pharmaceuticals Inc. | DFFN | LEVIN ALAN G Director | 13,100 | $3.15 | 13,100 (Direct) | View |
| 2019-06-13 Option Award | 2019-07-19 3:00 pm | N/A 2029-06-13 | Diffusion Pharmaceuticals Inc. | DFFN | Giles Mark T Director | 13,100 | $3.15 | 13,100 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-30 09:06 am | N/A 2029-01-02 | Diffusion Pharmaceuticals Inc. | DFFN | Byrne Thomas E General Counsel | 2,667 | $2.1 | 2,667 (Direct) | View |
| 2019-01-02 Option Award | 2019-01-04 4:01 pm | N/A 2029-01-02 | Diffusion Pharmaceuticals Inc. | DFFN | Hornung William Karl CFO | 16,334 | $2.1 | 16,334 (Direct) | View |
| 2018-06-14 Option Award | 2018-06-18 4:37 pm | N/A 2028-06-14 | Diffusion Pharmaceuticals Inc. | DFFN | Adams Robert W Director | 40,000 | $0.54 | 40,000 (Direct) | View |
| 2018-06-14 Option Award | 2018-06-18 4:37 pm | N/A 2028-06-14 | Diffusion Pharmaceuticals Inc. | DFFN | Giles Mark T Director | 40,000 | $0.54 | 40,000 (Direct) | View |
| 2018-06-14 Option Award | 2018-06-18 4:37 pm | N/A 2028-06-14 | Diffusion Pharmaceuticals Inc. | DFFN | LEVIN ALAN G Director | 40,000 | $0.54 | 40,000 (Direct) | View |
| 2018-06-14 Option Award | 2018-06-18 4:36 pm | N/A 2028-06-14 | Diffusion Pharmaceuticals Inc. | DFFN | RUFFOLO ROBERT R Director | 40,000 | $0.54 | 40,000 (Direct) | View |
| 2018-01-02 Option Award | 2018-01-04 4:03 pm | N/A 2028-01-02 | Diffusion Pharmaceuticals Inc. | DFFN | Byrne Thomas E General Counsel | 10,000 | $1.18 | 10,000 (Direct) | View |
| 2018-01-02 Option Award | 2018-01-04 4:03 pm | N/A 2028-01-02 | Diffusion Pharmaceuticals Inc. | DFFN | Shealy Ben VP | 25,000 | $1.18 | 25,000 (Direct) | View |
| 2018-01-02 Option Award | 2018-01-04 4:02 pm | N/A 2028-01-02 | Diffusion Pharmaceuticals Inc. | DFFN | LEVIN ALAN G Director | 25,000 | $1.18 | 25,000 (Direct) | View |
| 2018-01-02 Option Award | 2018-01-04 4:02 pm | N/A 2028-01-02 | Diffusion Pharmaceuticals Inc. | DFFN | Gainer John Chief Scientific Officer | 45,000 | $1.18 | 45,000 (Direct) | View |
| 2018-01-02 Option Award | 2018-01-04 4:01 pm | N/A 2028-01-02 | Diffusion Pharmaceuticals Inc. | DFFN | RUFFOLO ROBERT R Director | 25,000 | $1.18 | 25,000 (Direct) | View |
| 2018-01-02 Option Award | 2018-01-04 4:01 pm | N/A 2028-01-02 | Diffusion Pharmaceuticals Inc. | DFFN | Kalergis David G CEO Chairman | 55,000 | $1.18 | 55,000 (Direct) | View |
| 2018-01-02 Option Award | 2018-01-04 4:01 pm | N/A 2028-01-02 | Diffusion Pharmaceuticals Inc. | DFFN | Adams Robert W Director | 25,000 | $1.18 | 25,000 (Direct) | View |
| 2018-01-02 Option Award | 2018-01-04 4:01 pm | N/A 2028-01-02 | Diffusion Pharmaceuticals Inc. | DFFN | Giles Mark T Director | 25,000 | $1.18 | 25,000 (Direct) | View |
| 2017-06-29 Option Award | 2017-07-13 3:48 pm | N/A 2027-06-29 | Diffusion Pharmaceuticals Inc. | DFFN | RUFFOLO ROBERT R Director | 52,057 | $2.31 | 52,057 (Direct) | View |
| 2017-05-10 Option Award | 2017-06-30 4:03 pm | N/A 2027-05-10 | Diffusion Pharmaceuticals Inc. | DFFN | Kalergis David G CEO Chairman | 41,000 | $2.96 | 41,000 (Direct) | View |
| 2017-05-10 Option Award | 2017-06-30 4:02 pm | N/A 2027-05-10 | Diffusion Pharmaceuticals Inc. | DFFN | Gainer John Chief Scientific Officer | 34,000 | $2.96 | 34,000 (Direct) | View |
| 2017-05-10 Option Award | 2017-06-30 4:01 pm | N/A 2027-05-10 | Diffusion Pharmaceuticals Inc. | DFFN | Shealy Ben VP | 23,100 | $2.96 | 23,100 (Direct) | View |
| 2017-06-15 Option Award | 2017-06-16 5:29 pm | N/A 2027-06-15 | Diffusion Pharmaceuticals Inc. | DFFN | Giles Mark T Director | 23,900 | $2.4 | 23,900 (Direct) | View |
| 2017-06-15 Option Award | 2017-06-16 5:29 pm | N/A 2027-06-15 | Diffusion Pharmaceuticals Inc. | DFFN | Adams Robert W Director | 23,900 | $2.4 | 23,900 (Direct) | View |
| 2017-06-15 Option Award | 2017-06-16 5:29 pm | N/A 2027-06-15 | Diffusion Pharmaceuticals Inc. | DFFN | LEVIN ALAN G Director | 23,900 | $2.4 | 23,900 (Direct) | View |
| 2017-05-10 Option Award | 2017-05-12 5:33 pm | N/A 2027-05-10 | Diffusion Pharmaceuticals Inc. | DFFN | Shealy Ben VP | 23,100 | $2.95 | 23,100 (Direct) | View |
| 2017-05-10 Option Award | 2017-05-12 5:32 pm | N/A 2027-05-10 | Diffusion Pharmaceuticals Inc. | DFFN | Gainer John Chief Scientific Officer | 34,000 | $2.95 | 34,000 (Direct) | View |
| 2017-05-10 Option Award | 2017-05-12 5:32 pm | N/A 2027-05-10 | Diffusion Pharmaceuticals Inc. | DFFN | Kalergis David G CEO Chairman | 41,000 | $2.95 | 41,000 (Direct) | View |
| 2017-01-03 Option Award | 2017-01-04 4:15 pm | N/A 2027-01-03 | Diffusion Pharmaceuticals Inc. | DFFN | Byrne Thomas E General Counsel | 4,673 | $2.26 | 4,673 (Direct) | View |
| 2016-12-27 Other | 2016-12-28 4:15 pm | N/A N/A | Diffusion Pharmaceuticals Inc. | DFFN | Giles Mark T Director | 290,580 | $0 | 802,689 (Indirect) | View |
| 2016-12-14 Other | 2016-12-16 5:00 pm | N/A N/A | Diffusion Pharmaceuticals Inc. | DFFN | Giles Mark T Director | 339,055 | $0 | 512,109 (Indirect) | View |
| 2016-12-08 Option Award | 2016-12-13 4:27 pm | N/A 2026-12-08 | Diffusion Pharmaceuticals Inc. | DFFN | Adams Robert W Director | 14,000 | $2.74 | 14,000 (Direct) | View |
| 2016-12-08 Option Award | 2016-12-13 4:27 pm | N/A 2026-12-08 | Diffusion Pharmaceuticals Inc. | DFFN | Gainer John Chief Scientific Officer | 34,000 | $2.74 | 34,000 (Direct) | View |